What is she best known for?
The fields of study she is best known for:
Maria Luisa Mangoni focuses on Antimicrobial peptides, Biochemistry, Temporin, Microbiology and Peptide.
Her studies in Antimicrobial peptides integrate themes in fields like Pathogen, Immunology, Immune system, Innate immune system and Mode of action.
She regularly ties together related areas like Internal medicine in her Biochemistry studies.
Her Temporin research includes themes of Lipopolysaccharide, Gram-negative bacteria and Bacterial outer membrane.
Her Microbiology research is multidisciplinary, incorporating elements of Pseudomonas aeruginosa and Biofilm.
Her work carried out in the field of Peptide brings together such families of science as Proteolytic degradation and Escherichia coli.
Her most cited work include:
- Temporins, Antimicrobial Peptides from the European Red Frog Rana temporaria (278 citations)
- Antimicrobial peptides and wound healing: biological and therapeutic considerations (158 citations)
- Temporins, Small Antimicrobial Peptides with Leishmanicidal Activity (145 citations)
What are the main themes of her work throughout her whole career to date?
Maria Luisa Mangoni spends much of her time researching Antimicrobial peptides, Peptide, Microbiology, Antimicrobial and Biochemistry.
Maria Luisa Mangoni studies Temporin which is a part of Antimicrobial peptides.
While the research belongs to areas of Temporin, Maria Luisa Mangoni spends her time largely on the problem of Bacterial outer membrane, intersecting her research to questions surrounding Membrane permeability.
Her Peptide research incorporates elements of Amphibian, Biophysics and Stereochemistry, Circular dichroism.
Cystic fibrosis and Pseudomonas is closely connected to Pseudomonas aeruginosa in her research, which is encompassed under the umbrella topic of Microbiology.
In her research, Insulin is intimately related to Cytotoxicity, which falls under the overarching field of Antimicrobial.
She most often published in these fields:
- Antimicrobial peptides (62.77%)
- Peptide (41.61%)
- Microbiology (41.61%)
What were the highlights of her more recent work (between 2018-2021)?
- Antimicrobial peptides (62.77%)
- Antimicrobial (38.69%)
- Microbiology (41.61%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Antimicrobial peptides, Antimicrobial, Microbiology, Antibiotics and Peptide.
Her study on Antimicrobial peptides is covered under Biochemistry.
The various areas that Maria Luisa Mangoni examines in her Antimicrobial study include Quorum sensing, Lipopolysaccharide, Inhibitory postsynaptic potential, Cytotoxicity and Biological activity.
The concepts of her Microbiology study are interwoven with issues in Pseudomonas aeruginosa, Adjuvant, Cytokine and Biofilm.
Her study in Antibiotics is interdisciplinary in nature, drawing from both Methicillin-resistant Staphylococcus aureus and Staphylococcus aureus.
Her research investigates the connection between Peptide and topics such as Biophysics that intersect with issues in Teichoic acid, Cardiolipin and Cell wall.
Between 2018 and 2021, her most popular works were:
- Poly(lactide-co-glycolide) Nanoparticles for Prolonged Therapeutic Efficacy of Esculentin-1a-Derived Antimicrobial Peptides against Pseudomonas aeruginosa Lung Infection: in Vitro and in Vivo Studies (30 citations)
- Nigritanine as a New Potential Antimicrobial Alkaloid for the Treatment of Staphylococcus aureus-Induced Infections (17 citations)
- Inhibition of Pseudomonas aeruginosa biofilm formation and expression of virulence genes by selective epimerization in the peptide Esculentin-1a(1-21)NH2. (17 citations)
In her most recent research, the most cited papers focused on:
Maria Luisa Mangoni mostly deals with Antimicrobial, Microbiology, Antimicrobial peptides, Antibiotics and Pseudomonas aeruginosa.
Her Antimicrobial research is multidisciplinary, incorporating perspectives in Biological activity and Cytotoxicity.
Her Cytotoxicity research incorporates themes from Proline, Temporin, Pyrrolidine and Gram-positive bacteria.
Her Microbiology study combines topics from a wide range of disciplines, such as In vivo and PLGA.
Her study with Antimicrobial peptides involves better knowledge in Peptide.
The Pseudomonas aeruginosa study combines topics in areas such as In vitro, Cystic fibrosis, Mucus and Pseudomonas.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
